Critically Ill Pediatric Patient and SARS-CoV-2 Infection

Area of Science:

• Infectious Diseases
• Pediatric Critical Care
• Public Health

Background:

• The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the ongoing COVID-19 pandemic starting in December 2019.
• While initially focused on vulnerable elderly adults with comorbidities, COVID-19 significantly affects pediatric intensive care.
• Multisystemic inflammatory syndrome in children (MIS-C) emerged as a critical post-infection complication in early 2020.

Purpose of the Study:

• To highlight the persistent clinical challenges of COVID-19 in adult and pediatric intensive care settings in 2022.
• To underscore the impact of SARS-CoV-2 on pediatric populations, including the emergence of MIS-C.
• To acknowledge the ongoing threat despite available vaccinations and evolving viral landscape.

Main Methods:

• Review of clinical data and epidemiological trends related to COVID-19.
• Analysis of disease presentation and outcomes in adult and pediatric intensive care.
• Monitoring of viral mutations and vaccination efficacy in the context of the pandemic.

Main Results:

• COVID-19 remains a significant clinical challenge in intensive care units for both adults and children in 2022.
• Pediatric intensive care has been notably impacted, with the emergence of multisystemic inflammatory syndrome in children (MIS-C).
• Viral mutations and variable vaccination rates contribute to the ongoing clinical challenge.

Conclusions:

• COVID-19 continues to pose a substantial threat to critical care services globally in 2022.
• The pediatric population is significantly affected, necessitating vigilance for conditions like MIS-C.
• Ongoing viral evolution and vaccination disparities present persistent challenges in managing the pandemic.